Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 213981
Company: ZYDUS PHARMS

Products on ANDA 213981

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
BOSENTAN	BOSENTAN	32MG	TABLET, FOR SUSPENSION;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 213981

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/17/2026	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/03/2026	SUPPL-1	REMS - MODIFIED - D-N-A		Label is not available on this site.

Therapeutic Equivalents for ANDA 213981

BOSENTAN

TABLET, FOR SUSPENSION;ORAL; 32MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BOSENTAN	BOSENTAN	32MG	TABLET, FOR SUSPENSION;ORAL	Prescription	No	AB	213154	NATCO PHARMA LTD
BOSENTAN	BOSENTAN	32MG	TABLET, FOR SUSPENSION;ORAL	Prescription	No	AB	213981	ZYDUS PHARMS
TRACLEER	BOSENTAN	32MG	TABLET, FOR SUSPENSION;ORAL	Prescription	Yes	AB	209279	ACTELION